Dare Bioscience, Inc. Common Stock (NASDAQ: DARE) last traded at $0.820, up 1.32% on the session. The quote above updates while this page is open; the figures below are drawn from Dare Bioscience, Inc. Common Stock’s own filings and are restated only when a new one is published.
Dare Bioscience, Inc. Common Stock trades on NASDAQ under the ticker DARE. Its market capitalisation is $12.54 million.
Valuation measures for Dare Bioscience, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $12.54M |
|---|---|
| Enterprise value | $22.85M |
| Price / sales | 12.17 |
| Beta | 1.07 |
Trailing-twelve-month figures tagged in Dare Bioscience, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.03M |
|---|---|
| Net income (TTM) | -$10.99M |
| EPS (TTM) | -$0.660 |
| Operating margin | -1078.47% |
| Cash | $12.62M |
Range and volume for DARE over the past 52 weeks.
| 52-week high | $3.78 |
|---|---|
| 52-week low | $0.750 |
| Volume | 345.5K |
| Average volume | 462.2K |
| Previous close | $0.809 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.